BofA upgraded Cellebrite to Buy from Neutral with a $12 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLBT:
- Cellebrite Announces Fourth-Quarter 2023 Results
- Cellebrite Revolutionizes Investigative Workflow with Groundbreaking End-to-End Platform to Solve More Cases Faster
- Cellebrite announces Case-to-Closure platform
- Operation Find Them All: Cellebrite Unites Philanthropic Pioneers to Accelerate Investigations of Crimes Against Children
- Cellebrite enters collaboration for investigations of crimes against children